DALLAS, December 12, 2014 /PRNewswire/ --

RnRMarketResearch.com adds "Opioids Market Overview to 2023 - Opioids in Emerging Markets" industry research report with latest updates, data and information to its online business intelligence library.

The Opioids Market Overview to 2023 - Opioids in Emerging Markets report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential. Emphasis on restricting access to controlled drugs is much higher in emerging markets than in developed nations, resulting in a level of consumption that is too low to meet pain-control requirements even in cases of terminal illness. There is a high level of unmet need for pain control in both cancer and HIV/AIDS, and serious concerns have been raised regarding inadequate pain management in the emerging markets.

However, this is expected to change in the near future as regulatory authorities attempt to remedy the situation. Indeed, several new developments promise a better outlook for future access. Although India currently has a minor share of the market, it is expected to post a high growth rate (21.3% by 2023) due to improved access to opioid analgesics. Similarly, consumption in Brazil and Argentina is also expected to increase due to recent changes to their palliative care policies. Although the opioids market in emerging countries is small, it is expected to grow at a faster pace in forecast period than in some developed countries.

Opioids are largely used for two medicinal purposes: pain management and substitution treatment for drug dependence. Several of the recently approved and pipeline opioid analgesics have a strong focus on reducing misuse potential, which is one of the most significant barriers to usage in pain management. However, usage is on the rise following the introduction of new abuse-deterrent formulations of fentanyl and oxycodone, and initiatives that aim to rationalize usage in pain management. Demand is also high in substitution treatment. While both methadone and buprenorphine are approved for substitute treatment, buprenorphine usage increased in Europe after the approval of Suboxone in 2006, in combination with naloxone, a pure opioid antagonist that acts as an abuse-deterrent. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=237088 .

Scope of Opioids Market Overview to 2023 - Opioids in Emerging Markets Report covers: Discussion of the key challenges that restrict opioid use in pain management; Analysis of the inadequate use of opioids in pain control and the associated unmet need; Discussion of the key changes in the regulatory and legal landscape that affect opioids, prescription barriers, palliative care, and harm-reduction activities; Analysis of recent developments in emerging markets and their expected impact on opioid accessibility and usage; Country snapshots, which include key regulations, consumption, market revenues and forecasts, and key drivers and barriers in India, Brazil and South Africa; Snapshot of consumption trends along with market revenues and forecasts in Argentina and China. Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=249756 . (This is a premium report priced at US$2995 for a single user License.)

Key Reasons to Purchase Opioids Market Overview to 2023 - Opioids in Emerging Markets Report: 

• Understand the key constraints in emerging markets that limit the use of opioids in pain management
• Understand recent changes in the regulatory environment and gauge their impact on opioid usage
• Understand the market size and growth potential in emerging markets and identify high-potential countries for opioid products
• Gain a perspective of the opioids market size and key drivers and challenges that dictate the market trends in each of the five major countries in Western Europe
• Gauge the impact of key recently approved abuse-deterrent technologies on opioid usage
• Develop an understanding of how the regulatory landscape affects market potential and growth in each country
• Identify the key molecules that are currently the leading players in each region and those that hold the highest potential in the forecast period
• Scan the pipeline for innovative products with abuse-deterrent technologies that could have an impact on opioid usage in the pain management market

Explore more reports on Pain Management industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/pain-management .

About Us: 

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:  

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel:  +1-888-391-5441
sales@rnrmarketresearch.com

SOURCE RnR Market Research